How to biohack your cells to fight cancer - Greg Foot

TL;DR

Biohackers are reprogramming the immune system to fight cancer with CAR T-cell therapy.

Transcript

Ok, so you, are a 4 billion year old meat robot. Yeah, you heard me right. In fact, as you're made of 30-ish trillion cells, and each of those have their own task, you're a robot made of trillions of mini robots- you are a mega-meat-bot! And your mission, for the past 4 billion years or so- and for as long as you keep playing this game of life-... Read More

Key Insights

• 🤖 Humans are complex mega-meat-bots composed of trillions of cells safeguarding genetic code with errors fueling evolution.
• 🥺 Cancer arises from copying errors leading to rogue cells that synthetic biologists are targeting with CAR T-cell therapy.
• 😨 CAR T-cell therapy reprograms the immune system to recognize and destroy cancer cells, offering personalized and long-lasting treatment.
• ☠️ The therapy's effectiveness in blood cancers like leukemia has shown significant improvement in survival rates and remission outcomes.
• 👨‍💻 Biohackers are at the forefront of using science and technology to rewrite genetic code and enhance the body's capabilities against diseases like cancer.
• 😨 CAR T-cell therapy represents a transformative approach in cancer treatment, with ongoing research focusing on expanding its applications and efficacy.
• ♋ The personalized nature of CAR T-cell therapy offers promising results in blood cancers but faces challenges in broader cancer types due to specific antigen targeting requirements.

Questions & Answers

Q: What are humans described as in the context of genetic code and evolution?

Humans are seen as mega-meat-bots composed of trillions of cells tasked with safeguarding and passing on genetic code, despite errors driving evolution over billions of years.

Q: How does cancer arise, and what role do synthetic biologists play in combating it?

Cancer stems from copying errors causing cells to go rogue, but synthetic biologists are rewriting genetic code using CAR T-cell therapy to target cancer cells and improve treatment outcomes.

Q: What is CAR T-cell therapy, and how does it work in combating cancer?

CAR T-cell therapy involves reprogramming T-cells to recognize specific cancer antigens, destroy cancer cells, and stay in the bloodstream for years, offering a personalized and effective treatment approach.

Q: What are the challenges and future prospects of CAR T-cell therapy in cancer treatment?

Challenges include the high cost and specificity required for common cancers, but ongoing research aims to enhance CAR T-cell therapy for broader applications and improved survival rates in various cancer types.

Summary & Key Takeaways

• Humans are mega-meat-bots made up of trillions of cells, striving to safeguard and pass on genetic code with errors that drive evolution.

• Cancer arises from copying errors leading to rogue cells, but synthetic biologists are rewriting the code with CAR T-cell therapy.

• CAR T-cell therapy reprograms the immune system to target specific cancer antigens, offering promising results in blood cancers like leukemia.